Association of non-HLA genes with type 1 diabetes autoimmunity.

Approximately 50% of the genetic risk for type 1 diabetes is attributable to the HLA region. We evaluated associations between candidate genes outside the HLA region-INS, cytotoxic T-lymphocyte-associated antigen (CTLA)-4, interleukin (IL)-4, IL-4R, and IL-13 and islet autoimmunity among children participating in the Diabetes Autoimmunity Study in the Young (DAISY). Children with persistent islet autoantibody positivity (n = 102, 38 of whom have already developed diabetes) and control subjects (n = 198) were genotyped for single nucleotide polymorphisms (SNPs) in the candidate genes. The INS-23Hph1 polymorphism was significantly associated with both type 1 diabetes (OR = 0.30; 95% CI 0.13-0.69) and persistent islet autoimmunity but in the latter, only in children with the HLA-DR3/4 genotype (0.40; 0.18-0.89). CTLA-4 promoter SNP was significantly associated with type 1 diabetes (3.52; 1.22-10.17) but not with persistent islet autoimmunity. Several SNPs in the IL-4 regulatory pathway appeared to have a predisposing effect for type 1 diabetes. Associations were found between both IL-4R haplotypes and IL-4-IL-13 haplotypes and persistent islet autoimmunity and type 1 diabetes. This study confirms the association between the INS and CTLA-4 loci and type 1 diabetes. Genes involved in the IL-4 regulatory pathway (IL-4, IL-4R, IL-13) may confer susceptibility or protection to type 1 diabetes depending on individual SNPs or specific haplotypes.

[1]  D. Strachan,et al.  No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes. , 2005, American journal of human genetics.

[2]  M. McCarthy,et al.  In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk , 1995, Diabetologia.

[3]  M. Atkinson.  Timing of initial cereal exposure in infancy and risk of islet autoimmunity. , 2004, The Journal of pediatrics.

[4]  H. Erlich,et al.  Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. , 2003, American journal of human genetics.

[5]  L. Lazzeroni,et al.  Association of IL4R haplotypes with type 1 diabetes. , 2002, Diabetes.

[6]  W. Klitz,et al.  Association of CTLA-4 variation with type I diabetes in Filipinos , 2002, Immunogenetics.

[7]  P. Dřevínek,et al.  The CTLA4 +49 A/G dimorphism is not associated with type 1 diabetes in Czech children. , 2002, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[8]  L. Field.  Genetic linkage and association studies of Type I diabetes: challenges and rewards , 2002, Diabetologia.

[9]  N J Cox,et al.  Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. , 2001, American journal of human genetics.

[10]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[11]  M. Rewers,et al.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Sparholt,et al.  The polymorphisms S503P and Q576R in the interleukin‐4 receptor α gene are associated with atopy and influence the signal transduction , 1999, Immunology.

[13]  I. Djilali-Saiah,et al.  CTLA-4 GENE POLYMORPHISM IS ASSOCIATED WITH PREDISPOSITION TO COELIAC DISEASE. , 1998 .

[14]  T. Chatila,et al.  The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. , 1997, The New England journal of medicine.

[15]  K. Usadel,et al.  Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. , 1997, The Journal of clinical endocrinology and metabolism.

[16]  B. Weir.  Genetic Data Analysis II. , 1997 .

[17]  K. Usadel,et al.  CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  M. Rewers,et al.  Antiislet autoantibodies usually develop sequentially rather than simultaneously. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  W. Klitz,et al.  The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. , 1996, American journal of human genetics.

[20]  H. Chase,et al.  Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.

[21]  M. Rewers,et al.  Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY). , 1996, Journal of autoimmunity.

[22]  J. Todd,et al.  A genome-wide search for human type 1 diabetes susceptibility genes , 1994, Nature.

[23]  H. Heimberg,et al.  5′ Insulin Gene Polymorphism Confers Risk to IDDM Independently of HLA Class II Susceptibility , 1993, Diabetes.

[24]  G. Lathrop,et al.  Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility , 1991, Nature.

[25]  N. Copeland,et al.  The interleukin-4 receptor gene (IL4R) maps to 16p11.2-16p12.1 in human and to the distal region of mouse chromosome 7. , 1991, Genomics.

[26]  J. Karam,et al.  A Polymorphic Locus Near the Human Insulin Gene Is Associated with Insulin-dependent Diabetes Melliitus , 1984, Diabetes.